Jaguar Health Inc (NASDAQ:JAGX) Stock Reports Quarterly Earnings: Stock Falls
Jaguar Health Inc (NASDAQ:JAGX) fell 6.75% after announcing its consolidated Q2 2021 financial results. During the quarter Mytesi, prescription volume was up 4.3% from Q1 2021, with net prescriptions increasing 2.8% over the same period. However, YoY prescription volume was down 9%, which the company attributes to the role of the pandemic leading to fewer patient visits, few refills, and fewer opportunities for Mytesi patients’ diagnosis. Mytesus net revenue was…